L Lebrun

1.0k total citations
30 papers, 751 citations indexed

About

L Lebrun is a scholar working on Infectious Diseases, Public Health, Environmental and Occupational Health and Epidemiology. According to data from OpenAlex, L Lebrun has authored 30 papers receiving a total of 751 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 10 papers in Public Health, Environmental and Occupational Health and 8 papers in Epidemiology. Recurrent topics in L Lebrun's work include Streptococcal Infections and Treatments (9 papers), Antimicrobial Resistance in Staphylococcus (5 papers) and Tuberculosis Research and Epidemiology (4 papers). L Lebrun is often cited by papers focused on Streptococcal Infections and Treatments (9 papers), Antimicrobial Resistance in Staphylococcus (5 papers) and Tuberculosis Research and Epidemiology (4 papers). L Lebrun collaborates with scholars based in France, Netherlands and Germany. L Lebrun's co-authors include Jean‐Dominique Poveda, F. Espinasse, Jacques Grober, Patrice Nordmann, D Mathieu, Naïg Le Guern, J Pillot, Jean-Paul Paı̈s de Barros, Valérie Deckert and Laurent Lagrost and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and Journal of Clinical Microbiology.

In The Last Decade

L Lebrun

27 papers receiving 713 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L Lebrun France 11 373 368 181 149 92 30 751
Orhan Cem Aktepe Türkiye 16 297 0.8× 99 0.3× 103 0.6× 110 0.7× 65 0.7× 55 745
Heather Henderson United States 14 390 1.0× 367 1.0× 170 0.9× 89 0.6× 11 0.1× 34 848
H G Muchmore United States 16 467 1.3× 419 1.1× 69 0.4× 54 0.4× 35 0.4× 47 838
Robert H. Waldman United States 17 338 0.9× 149 0.4× 105 0.6× 101 0.7× 38 0.4× 31 901
Buket Cicioğlu Arıdoğan Türkiye 16 164 0.4× 187 0.5× 95 0.5× 156 1.0× 48 0.5× 60 773
Hafid Soualhine Canada 13 443 1.2× 345 0.9× 94 0.5× 254 1.7× 38 0.4× 37 985
Joseph Taboada United States 15 136 0.4× 163 0.4× 75 0.4× 40 0.3× 113 1.2× 37 610
N Moon United States 8 401 1.1× 456 1.2× 234 1.3× 164 1.1× 8 0.1× 8 938
U. Banerjee India 17 437 1.2× 373 1.0× 24 0.1× 86 0.6× 55 0.6× 38 894
Christopher Vinnard United States 15 413 1.1× 448 1.2× 241 1.3× 79 0.5× 67 0.7× 45 817

Countries citing papers authored by L Lebrun

Since Specialization
Citations

This map shows the geographic impact of L Lebrun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L Lebrun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L Lebrun more than expected).

Fields of papers citing papers by L Lebrun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L Lebrun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L Lebrun. The network helps show where L Lebrun may publish in the future.

Co-authorship network of co-authors of L Lebrun

This figure shows the co-authorship network connecting the top 25 collaborators of L Lebrun. A scholar is included among the top collaborators of L Lebrun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L Lebrun. L Lebrun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Lebrun, L, et al.. (2025). Borrelia spielmanii–Associated Neuroborreliosis in Patient Receiving Rituximab, Belgium. Emerging infectious diseases. 31(2). 341–344. 1 indexed citations
3.
Lebrun, L, et al.. (2023). Activation of TLRs Triggers GLP-1 Secretion in Mice. International Journal of Molecular Sciences. 24(6). 5333–5333. 8 indexed citations
4.
Lebrun, L, et al.. (2022). Postprandial consequences of lipid absorption in the onset of obesity: Role of intestinal CD36. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1867(7). 159154–159154. 9 indexed citations
5.
Lebrun, L & Jacques Grober. (2018). Could glucagon-like peptide-1 be a potential biomarker of early-stage intestinal ischemia?. Biochimie. 159. 107–111. 6 indexed citations
6.
Deckert, Valérie, Stéphanie Barrère‐Lemaire, Jean-Paul Paı̈s de Barros, et al.. (2017). Recombinant human plasma phospholipid transfer protein (PLTP) to prevent bacterial growth and to treat sepsis. Scientific Reports. 7(1). 3053–3053. 28 indexed citations
7.
Lebrun, L, Kaatje Lenaerts, Dorien Kiers, et al.. (2017). Enteroendocrine L Cells Sense LPS after Gut Barrier Injury to Enhance GLP-1 Secretion. Cell Reports. 21(5). 1160–1168. 174 indexed citations
8.
Dailloux, M., et al.. (2006). Respiratory infections associated with nontuberculous mycobacteria in non-HIV patients. European Respiratory Journal. 28(6). 1211–1215. 85 indexed citations
9.
Casetta, Anne, et al.. (2003). Emergence of nosocomial Pseudomonas aeruginosa colonization/infection in pregnant women with preterm premature rupture of membranes and in their neonates. Journal of Hospital Infection. 54(2). 158–160. 11 indexed citations
10.
Naas, Thierry, et al.. (2001). Molecular Identification of TEM-1 β-Lactamase in a Pasteurella multocida Isolate of Human Origin. European Journal of Clinical Microbiology & Infectious Diseases. 20(3). 210–213. 36 indexed citations
11.
Gutiérrez, M. Cristina, V. Vincent, Dominique Aubert, et al.. (1998). Molecular Fingerprinting of Mycobacterium tuberculosis and Risk Factors for Tuberculosis Transmission in Paris, France, and Surrounding Area. Journal of Clinical Microbiology. 36(2). 486–492. 100 indexed citations
12.
Lebrun, L, D Mathieu, C Saulnier, & Patrice Nordmann. (1997). Limits of commercial molecular tests for diagnosis of pulmonary tuberculosis. European Respiratory Journal. 10(8). 1874–1876. 24 indexed citations
13.
Guibert, M, et al.. (1991). [Value and limitations of the research of Mycoplasma hominis and Ureaplasma urealyticum in gastric fluid in newborn infants].. PubMed. 39(4). 287–9. 1 indexed citations
14.
Lebrun, L, et al.. (1986). Human Fc(gamma) receptors for differentiation in throat cultures of group C "Streptococcus equisimilis" and group C "Streptococcus milleri". Journal of Clinical Microbiology. 24(5). 705–707. 9 indexed citations
15.
Lebrun, L, et al.. (1983). Detection of Legionella pneumophila antigen by ELISA in urine or experimentally infected guinea-pigs.. PubMed. 134A(2). 155–61. 1 indexed citations
16.
Grangeot‐Keros, L., L Lebrun, Selim Badur, E Sacquet, & J Pillot. (1983). Caractérisation de l'antigène des complexes immuns circulants et application à la mise en évidence d'antigènes streptococciques lors des endocardites infectieuses humaines. Annales de l Institut Pasteur Immunologie. 134(2). 275–280. 1 indexed citations
17.
Lebrun, L, J Pillot, & L. Grangeot‐Keros. (1982). Significance of anti-IgG antibodies obtained by immunization of rabbits with some streptococcal strains. Annales de l Institut Pasteur Immunologie. 133(1). 45–56. 16 indexed citations
18.
Grangeot‐Keros, L., et al.. (1982). A critical study of the use of staphylococci containing protein A for separation of IgG and IgM antibodies. Journal of Immunological Methods. 51(2). 183–195. 6 indexed citations
19.
Lebrun, L, et al.. (1980). Maladie des légionnaires. Spécificité du diagnostic par immunofluorescence. Deux observations.. ˜La œNouvelle presse médicale. 9(38). 2849–2849. 2 indexed citations
20.
Lebrun, L, et al.. (1977). [Identification of pathogenic streptococci. Grouping by co-agglutination].. PubMed. 6(21). 1882–1882. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Orhan Cem Aktepe Breakdown of academic impact, for papers by Heather Henderson Breakdown of academic impact, for papers by H G Muchmore Breakdown of academic impact, for papers by Robert H. Waldman Breakdown of academic impact, for papers by Buket Cicioğlu Arıdoğan Breakdown of academic impact, for papers by Hafid Soualhine Breakdown of academic impact, for papers by Joseph Taboada Breakdown of academic impact, for papers by N Moon Breakdown of academic impact, for papers by U. Banerjee Breakdown of academic impact, for papers by Christopher Vinnard
Rankless by CCL
2026